Number of the records: 1
Ki-1 antigén
SYS d017730 LBL 00000cz--a2200000n--4500 005 20250606212944.8 008 921228|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D12.776.543.750.705.852.760.072 065 $a D23.050.285.025 065 $a D23.101.140.055 066 $a 01 $c 03 150 $a Ki-1 antigén $x AD $x AG $x AI $x AN $x BI $x BL $x CH $x CL $x DE $x DF $x GE $x HI $x IM $x IP $x ME $x PH $x RE $x TU $x UL $2 slo 450 $w v $a Antigens, CD30 $2 eng 450 $w v $a Antigens, Ki-1 $2 eng 450 $w v $a Ber-H2 Antigens $2 eng 450 $w v $a CD30 Antigens $2 eng 450 $w v $a Ki-1 Antigens $2 eng 450 $w v $a Tumor Necrosis Factor Receptor Superfamily, Member 8 $2 eng 450 $w v $a antigény CD30 $2 slo 450 $w v $a antigény Ber-H2 $2 slo 450 $w v $a TNFRSF8 receptor $2 slo 450 $w v $a veľkorodina receptorov pre faktor nekrotizujúci nádory, člen 8 $2 slo 450 $w v $a superrodina receptorov pre faktor nekrotizujúci nádory, člen 8 $2 slo 550 $7 sllk_us_auth*d017728 $Y Lymphoma, Large-Cell, Anaplastic $w b $a lymfóm veľkobunkový anaplastický 665 $a 2018 (1983) $2 eng 665 $a Antigens, CD (1990-1993) $2 eng 665 $a Antigens, Differentiation (1988-1993) $2 eng 665 $a Antigens, Neoplasm (1985-1993) $2 eng 680 9-
$i A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. $2 eng 750 -2
$a Ki-1 Antigen $2 eng 980 $x M
Number of the records: 1